Initial Management of Wheezing and Congestion in a 3-Year-Old

Immediate Clinical Assessment

The American Thoracic Society recommends assessing for features of acute severe asthma, such as too breathless to feed, respiratory rate >50 breaths/minute, pulse >140 beats/minute, use of accessory muscles, or oxygen saturation <92% in a 3-year-old with wheezing and congestion 1, 2
Identifying life-threatening features, such as poor respiratory effort, silent chest, cyanosis, exhaustion, agitation, or reduced consciousness, is crucial in a 3-year-old with wheezing and congestion 1, 2

The British Thoracic Society recommends administering salbutamol 2.5 mg via nebulizer (half the standard 5 mg dose for children >2 years) in a 3-year-old with suspected asthma exacerbation 1, 2
The American Academy of Pediatrics suggests an alternative delivery of 4-8 puffs via MDI with large volume spacer every 20 minutes for up to 3 doses in the first hour in a 3-year-old with suspected asthma exacerbation 3, 4

The National Asthma Education and Prevention Program recommends administering oral prednisolone 1-2 mg/kg (maximum 40 mg) immediately if any features of acute severe asthma are present or if the child has failed to respond adequately to initial bronchodilator therapy in a 3-year-old with wheezing and congestion 1, 2, 3, 4
The American College of Chest Physicians suggests not delaying corticosteroids while giving repeated albuterol doses alone, as underuse of corticosteroids is specifically identified as a leading cause of preventable asthma mortality in a 3-year-old with wheezing and congestion 2, 3

The American Academy of Pediatrics recommends adding ipratropium 100 mcg to the nebulizer if the child fails to respond to initial beta-agonist therapy or has severe features at presentation in a 3-year-old with wheezing and congestion 1, 2, 3

The British Thoracic Society suggests administering high-flow oxygen via face mask to maintain oxygen saturation >92% if hypoxemia is present in a 3-year-old with wheezing and congestion 1, 2, 3, 4

The American Academy of Allergy, Asthma, and Immunology recommends initiating daily inhaled corticosteroids as the preferred long-term controller therapy if this represents recurrent wheezing (>3 episodes in past year with risk factors) in a 3-year-old with wheezing and congestion 5
The National Asthma Education and Prevention Program suggests alternative options, including montelukast 4 mg chewable tablet (FDA-approved for ages 2-6 years) or budesonide nebulizer solution (FDA-approved for children 1-8 years of age) in a 3-year-old with recurrent wheezing 5